6.615
4.55%
-0.315
GoodRx Holdings Inc 주식(GDRX)의 최신 뉴스
GoodRx (GDRX) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research
GoodRx (GDRX) Q1 2024 Earnings Call Transcript
The Motley Fool
GoodRx Holdings, Inc. (GDRX) Misses Q1 Earnings Estimates
Zacks Investment Research
Premier, Inc. (PINC) Q3 Earnings and Revenues Surpass Estimates
Zacks Investment Research
Countdown to GoodRx (GDRX) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Zacks Investment Research
Is GoodRx (GDRX) Outperforming Other Medical Stocks This Year?
Zacks Investment Research
GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings
Benzinga
ELV vs. GDRX: Which Stock Is the Better Value Option?
Zacks Investment Research
Why GoodRx Surged Today
The Motley Fool
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says
Benzinga
The Latest Analyst Ratings For GoodRx Holdings
Benzinga
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Benzinga
ELV or GDRX: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Wall Street Analysts Predict a 29.1% Upside in GoodRx Holdings, Inc. (GDRX): Here's What You Should Know
Zacks Investment Research
Encompass Health (EHC), Piedmont to Build Loganville Facility
Zacks Investment Research
ELV or GDRX: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Can GoodRx Holdings, Inc. (GDRX) Run Higher on Rising Earnings Estimates?
Zacks Investment Research
GoodRx Holdings, Inc. (GDRX) is a Great Momentum Stock: Should You Buy?
Zacks Investment Research
GoodRx Holdings, Inc. (GDRX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
These Analysts Increase Their Forecasts On GoodRx Following Q4 Earnings
Benzinga
Why GoodRx Stock Soared Today
The Motley Fool
GoodRx (GDRX) Q4 2023 Earnings Call Transcript
The Motley Fool
GoodRx Holdings, Inc. (GDRX) Matches Q4 Earnings Estimates
Zacks Investment Research
Agiliti (AGTI) Expected to Beat Earnings Estimates: Should You Buy?
Zacks Investment Research
What to Look for in Crescent Point's (CPG) Q4 Earnings?
Zacks Investment Research
Countdown to GoodRx Holdings, Inc. (GDRX) Q4 Earnings: Wall Street Forecasts for Key Metrics
Zacks Investment Research
In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings
Benzinga
What Will Global Partners' (GLP) Q4 Earnings Unveil?
Zacks Investment Research
GoodRx Holdings, Inc. (GDRX) Reports Next Week: What Awaits?
Zacks Investment Research
What's in the Cards for Medtronic (MDT) in Q3 Earnings?
Zacks Investment Research
DaVita (DVA) to Report Q4 Earnings: What's in the Offing?
Zacks Investment Research
Labcorp (LH) to Report Q4 Earnings: What's in the Cards? (Revised)
Zacks Investment Research
Can Tenet's (THC) Q4 Earnings Beat on Rising Patient Admissions?
Zacks Investment Research
Catalent (CTLT) to Report Q2 Earnings: What's in the Cards?
Zacks Investment Research
Encompass Health (EHC) to Post Q4 Earnings: What's in Store?
Zacks Investment Research
Labcorp (LH) to Report Q4 Earnings: What's in the Cards?
Zacks Investment Research
Will High Medical Costs Affect Centene's (CNC) Q4 Earnings?
Zacks Investment Research
How Much Upside is Left in GoodRx Holdings, Inc. (GDRX)? Wall Street Analysts Think 27.83%
Zacks Investment Research
Cigna (CI) to Report Q4 Earnings: Can Rising Expenses Hurt?
Zacks Investment Research
STERIS (STE) Set to Post Q3 Earnings: What's in the Cards?
Zacks Investment Research
Can Higher Costs Affect HCA Healthcare's (HCA) Q4 Earnings?
Zacks Investment Research
Earnings Estimates Rising for GoodRx Holdings, Inc. (GDRX): Will It Gain?
Zacks Investment Research
What Makes GoodRx Holdings, Inc. (GDRX) a Strong Momentum Stock: Buy Now?
Zacks Investment Research
After Golden Cross, GoodRx Holdings, Inc. (GDRX)'s Technical Outlook is Bright
Zacks Investment Research
GoodRx Holdings, Inc. (GDRX) Surges 13.3%: Is This an Indication of Further Gains?
Zacks Investment Research
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
Benzinga
Unveiling 7 Analyst Insights On GoodRx Holdings
Benzinga
자본화:
|
볼륨(24시간):